Progressive vaccinia treated with ribavirin and vaccinia immune globulin

Clinical Infectious Diseases

Volumn 25, Issue 4, 1997, Pages 911-914

  Kesson, Alison M ^b   Ferguson, John K ^c   Rawlinson, William D ^c   Cunningham, Anthony L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b ROYAL NEWCASTLE HOSPITAL   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUCLOXACILLIN; IMMUNOGLOBULIN; RIBAVIRIN; VACCINIA ONCOLYSATE;

AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CASE REPORT; CELLULITIS; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; HUMAN; INJECTION SITE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MELANOMA; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINIA;

EID: 0030843341     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515534     Document Type: Article

References (16)

1. Neff JM. Vaccinia virus (cowpox). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1325-27.
2. Hersey P, Edwards A, Coates A, Shaw H, McCarthy W, Milton G. Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of Stage II melanoma with viral lysates. Cancer Immunol Immunother 1987;25:257-65.
3. Chang T-W, Heel RC. Ribavirin and inosiplex: a review of their present status in viral diseases. Drugs 1981;22:111-28.
4. WHO. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:145-52.
5. Kempe CH. Studies on smallpox and complications of smallpox vaccination. Pediatrics 1960;26:176-89.
6. Blanden RV. Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum. J Exp Med 1970;132:1035-54.
7. Blanden RV. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med 1971;133:1074-89.
8. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: World Health Organization. 1988:296-311.
9. Feteky FR Jr, Malawista SE, Young DL. Vaccinia gangrenosa in chronic lymphatic leukemia: report of a case with recovery following the use of vaccinia immune globulin. Arch Intern Med 1962;109:205-8.
10. Bauer D. Clinical experience with the antiviral drug Marboran (1-methylisatin 3-thiosemicarbazone). Ann NY Acad Sci 1965;130:110-7.
11. Brainerd H, Hanna L, Jawetz E. Methisazone in progressive vaccinia. N Engl J Med 1967;276:620-2.
12. Kucers A, Bennett N McK. Ribavirin. In: Kucers A, Bennett N McK, Kemp RJ, eds. The use of antibiotics. A comprehensive review with clinical emphasis. 4th ed. Philadelphia: JB Lippincott, 1987:1607-12.
13. Douglas RG Jr, Lynch EC, Spira M. Treatment of progressive vaccinia. Use of methisazone, vaccinia immune serum globulin, and surgical debridement. Arch Intern Med 1972;129:980-3.
14. Moss B. Vaccinia virus: a tool for research and vaccine development. Science 1991;252:1662-7.
15. Ramshaw IA, Andrew ME, Phillips SM, Boyle DB, Coupar BEH. Recovery of immunodeficient mice from vaccinia virus/IL-2 recombinant infection [letter]. Nature 1987;329:545-6.
16. Ramsay AJ, Ruby J, Ramshaw IA. A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 1993;14:155-7.